blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2340025

EP2340025 - CGRP RECEPTOR ANTAGONISTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.08.2015
Database last updated on 18.11.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
[2014/42]
Former [2012/33]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway NJ 07065-0907 / US
Former [2011/27]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
Inventor(s)01 / STAAS, Donnette, D.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
02 / BELL, Ian, M.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
03 / SELNICK, Harold, G.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
 [2011/27]
Representative(s)Buchan, Gavin MacNicol
Merck & Co., Inc.
European Patent Department
Hertford Road
Hoddesdon, Hertfordshire EN11 9BU / GB
[2014/42]
Former [2011/27]Buchan, Gavin MacNicol
Merck & Co., Inc. European Patent Department Hertford Road
Hoddesdon, Hertfordshire EN11 9BU / GB
Application number, filing date09818345.229.09.2009
[2011/27]
WO2009US58711
Priority number, dateUS20080195146P03.10.2008         Original published format: US 195146 P
[2011/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010039673
Date:08.04.2010
Language:EN
[2010/14]
Type: A1 Application with search report 
No.:EP2340025
Date:06.07.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 08.04.2010 takes the place of the publication of the European patent application.
[2011/27]
Type: B1 Patent specification 
No.:EP2340025
Date:15.10.2014
Language:EN
[2014/42]
Search report(s)International search report - published on:US08.04.2010
(Supplementary) European search report - dispatched on:EP12.04.2012
ClassificationIPC:A61K31/55, C07D498/10, C07D498/20, A61P29/00
[2012/19]
CPC:
C07D498/20 (EP,US); A61P25/00 (EP); A61P25/04 (EP);
A61P25/06 (EP); A61P29/00 (EP); C07D498/04 (EP,US);
C07D498/10 (EP,US) (-)
Former IPC [2011/27]A61K31/55
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/27]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:CGRP-REZEPTORANTAGONISTEN[2011/27]
English:CGRP RECEPTOR ANTAGONISTS[2011/27]
French:ANTAGONISTES DES RÉCEPTEURS CGRP[2011/27]
Entry into regional phase03.05.2011National basic fee paid 
03.05.2011Search fee paid 
03.05.2011Designation fee(s) paid 
03.05.2011Examination fee paid 
Examination procedure03.05.2011Examination requested  [2011/27]
07.11.2012Amendment by applicant (claims and/or description)
11.06.2013Despatch of a communication from the examining division (Time limit: M04)
09.10.2013Reply to a communication from the examining division
30.04.2014Communication of intention to grant the patent
15.08.2014Receipt of the translation of the claim(s)
18.08.2014Fee for grant paid
18.08.2014Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.06.2013
Opposition(s)16.07.2015No opposition filed within time limit [2015/39]
Fees paidRenewal fee
08.09.2011Renewal fee patent year 03
26.09.2012Renewal fee patent year 04
09.09.2013Renewal fee patent year 05
08.09.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.09.2009
AT15.10.2014
BE15.10.2014
BG15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
ES15.10.2014
FI15.10.2014
HR15.10.2014
IT15.10.2014
LT15.10.2014
LV15.10.2014
MC15.10.2014
MK15.10.2014
MT15.10.2014
NL15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SI15.10.2014
SK15.10.2014
SM15.10.2014
TR15.10.2014
NO15.01.2015
GR16.01.2015
IS15.02.2015
PT16.02.2015
[2018/30]
Former [2017/46]HU29.09.2009
AT15.10.2014
BE15.10.2014
BG15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
ES15.10.2014
FI15.10.2014
HR15.10.2014
IT15.10.2014
LT15.10.2014
LV15.10.2014
MC15.10.2014
MT15.10.2014
NL15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SI15.10.2014
SK15.10.2014
SM15.10.2014
TR15.10.2014
NO15.01.2015
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2017/38]HU29.09.2009
AT15.10.2014
BG15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
ES15.10.2014
FI15.10.2014
HR15.10.2014
IT15.10.2014
LT15.10.2014
LV15.10.2014
MC15.10.2014
MT15.10.2014
NL15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SI15.10.2014
SK15.10.2014
SM15.10.2014
TR15.10.2014
NO15.01.2015
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2017/21]AT15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
ES15.10.2014
FI15.10.2014
HR15.10.2014
IT15.10.2014
LT15.10.2014
LV15.10.2014
MC15.10.2014
MT15.10.2014
NL15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SI15.10.2014
SK15.10.2014
NO15.01.2015
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2016/23]AT15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
ES15.10.2014
FI15.10.2014
HR15.10.2014
IT15.10.2014
LT15.10.2014
LV15.10.2014
MC15.10.2014
NL15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SI15.10.2014
SK15.10.2014
NO15.01.2015
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2016/12]AT15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
ES15.10.2014
FI15.10.2014
HR15.10.2014
IT15.10.2014
LT15.10.2014
LV15.10.2014
NL15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SI15.10.2014
SK15.10.2014
NO15.01.2015
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/37]AT15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
ES15.10.2014
FI15.10.2014
HR15.10.2014
IT15.10.2014
LT15.10.2014
LV15.10.2014
NL15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SK15.10.2014
NO15.01.2015
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/36]AT15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
ES15.10.2014
FI15.10.2014
HR15.10.2014
LT15.10.2014
LV15.10.2014
NL15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
NO15.01.2015
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/35]AT15.10.2014
CY15.10.2014
DK15.10.2014
EE15.10.2014
ES15.10.2014
FI15.10.2014
HR15.10.2014
LT15.10.2014
LV15.10.2014
NL15.10.2014
PL15.10.2014
SE15.10.2014
NO15.01.2015
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/34]AT15.10.2014
CY15.10.2014
DK15.10.2014
ES15.10.2014
FI15.10.2014
HR15.10.2014
LT15.10.2014
LV15.10.2014
NL15.10.2014
PL15.10.2014
SE15.10.2014
NO15.01.2015
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/26]AT15.10.2014
CY15.10.2014
ES15.10.2014
FI15.10.2014
HR15.10.2014
LT15.10.2014
LV15.10.2014
NL15.10.2014
PL15.10.2014
SE15.10.2014
NO15.01.2015
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/25]AT15.10.2014
ES15.10.2014
FI15.10.2014
HR15.10.2014
LT15.10.2014
LV15.10.2014
NL15.10.2014
PL15.10.2014
SE15.10.2014
NO15.01.2015
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/24]ES15.10.2014
FI15.10.2014
HR15.10.2014
LT15.10.2014
LV15.10.2014
NL15.10.2014
PL15.10.2014
SE15.10.2014
NO15.01.2015
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/23]ES15.10.2014
FI15.10.2014
LT15.10.2014
NL15.10.2014
NO15.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/22]LT15.10.2014
NL15.10.2014
NO15.01.2015
PT16.02.2015
Former [2015/21]LT15.10.2014
NL15.10.2014
NO15.01.2015
Former [2015/20]LT15.10.2014
NL15.10.2014
Former [2015/16]NL15.10.2014
Documents cited:Search[Y]WO2006029153  (MERCK & CO INC [US], et al) [Y] 1-21 * page 1, line 5 - page 3, line 15; example -; claim - *;
 [Y]WO2008073251  (MERCK & CO INC [US], et al) [Y] 1-21 * page 1, line 5 - page 3, line 3; example -; claim - *;
 [Y]US2006148779  (BELL IAN M [US], et al) [Y] 1-21 * page 1, paragraph 1 - paragraph 5; example -; claim - *
International search[X]US2007265225  (WOOD MICHAEL R [US], et al)
by applicantUS2007265225
    - GOADSBY ET AL., ANN. NEUROL., (1990), vol. 28, pages 183 - 187
    - BELLAMY ET AL., HEADACHE, (2006), vol. 46, pages 24 - 33
    - LASSEN ET AL., CEPHALALGIA, (2002), vol. 22, pages 54 - 61
    - OLESEN ET AL., NEW ENGL. J. MED., (2004), vol. 350, pages 1104 - 1110
    - PETERSEN ET AL., CLIN. PHARMACOL. THER., (2005), vol. 77, pages 202 - 213
    - LANCE, Headache Pathogenesis: Monoamines, Neuropeptides, Purines and Nitric Oxide, LIPPINCOTT-RAVEN PUBLISHERS, (1997), pages 3 - 9
    - GOADSBY ET AL., ANN. NEUROL., (1988), vol. 23, pages 193 - 196
    - WILLIAMSON ET AL., CEPHALALGIA, (1997), vol. 17, pages 525 - 531
    - ESCOTT ET AL., BRAIN RES., (1995), vol. 669, pages 93 - 99
    - DOODS ET AL., BR. J. PHARMACOL., (2000), vol. 129, pages 420 - 423
    - "The CGRP Family: Calcitonin Gene-Related Peptide", WILLIAMSON ET AL., Amylin, and Adrenomedullin, LANDES BIOSCIENCE, (2000), pages 245 - 247
    - BURSTEIN ET AL., ANN. NEUROL., (2000), vol. 47, pages 614 - 624
    - DOODS, CURR OPIN INVES DRUGS, (2001), vol. 2, no. 9, pages 1261 - 1268
    - EDVINSSON ET AL., CEPHALALGIA, (1994), vol. 14, pages 320 - 327
    - ASHINA ET AL., NEUROLOGY, (2000), vol. 14, pages 1335 - 1340
    - YU ET AL., EUR. J. PHARM., (1998), vol. 347, pages 275 - 282
    - HULSEBOSCH ET AL., PAIN, (2000), vol. 86, pages 163 - 175
    - HOLZER, NEUROSCI., (1988), vol. 24, pages 739 - 768
    - DELAY-GOYET ET AL., ACTA PHYSIOL. SCANDA, (1992), vol. 146, pages 537 - 538
    - SALMON ET AL., NATURE NEUROSCI., (2001), vol. 4, no. 4, pages 357 - 358
    - MAY ET AL., CEPHALALGIA, (2002), vol. 22, pages 195 - 196
    - AWAWDEH ET AL., INT. ENDOCRIN. J., (2002), vol. 35, pages 30 - 36
    - MOLINA ET AL., DIABETES, (1990), vol. 39, pages 260 - 265
    - ZHANG ET AL., PAIN, (2001), vol. 89, page 265
    - FOSTER ET AL., ANN. NY ACAD. SCI., (1992), vol. 657, pages 397 - 404
    - SCHINI ET AL., AM. J. PHYSIOL., (1994), vol. 267, pages H2483 - H2490
    - ZHENG ET AL., J. VIROL., (1993), vol. 67, pages 5786 - 5791
    - BEER ET AL., CRIT. CARE MED., (2002), vol. 30, no. 8, pages 1794 - 1798
    - MENARD ET AL., J. NEUROSCI., (1996), vol. 16, no. 7, pages 2342 - 2351
    - CHEN ET AL., LANCET, (1993), vol. 342, page 49
    - SPETZ ET AL., J. UROLOGY, (2001), vol. 166, pages 1720 - 1723
    - WALLENGREN, CONTACT DERMATITIS, (2000), vol. 43, no. 3, pages 137 - 143
    - ROHRENBECK ET AL., NEUROBIOL. OF DISEASE, (1999), vol. 6, pages 15 - 34
    - HERZOG ET AL., J. MEMBRANE BIOLOGY, (2002), vol. 189, no. 3, page 225
    - HOFFMAN ET AL., SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, (2002), vol. 37, no. 4, pages 414 - 422
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.